Ovid Therapeutics (OVID) Operating Leases (2022 - 2026)
Ovid Therapeutics' Operating Leases came in at $11.23 million for Q2 2026, down 11.7% from $12.72 million a year earlier and down 3.3% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Ovid Therapeutics' Operating Leases was $11.99 million, down 10.7% from FY2024.
- Operating Leases has declined in each of the last three years, with a three-year compound annual growth rate of -9.2% (FY2022 to FY2025).
- Going back by year, Operating Leases was $13.42 million in FY2024 (-9.1%), $14.76 million in FY2023 (-7.8%) and $16 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Operating Leases in data going back to Q1 2022.
- Year-over-year, Operating Leases has declined for 11 consecutive quarters, with an average decline of 10.1% over the last eight quarters.
- Across the past five years, year-over-year decline in Operating Leases ran from 1.1% in Q1 2023 to 11.7% in Q2 2026.
- Business Quant data shows OVID's Operating Leases at $11.61 million (Q1 2026), $11.99 million (Q4 2025) and $12.35 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,135.99 Bn | 1,104.58 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 616.90 Bn | 535.42 Bn | 17.26 Bn |
| 3 | AbbVie | 501.56 Bn | 474.68 Bn | 12.70 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.45 Bn | 235.13 Bn | 12.86 Bn |
| 7 | Amgen | 236.48 Bn | 191.88 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 190.56 Bn | 164.76 Bn | 6.22 Bn |
| 9 | Pfizer | 169.46 Bn | 116.11 Bn | 10.94 Bn |
| 10 | Ovid Therapeutics | 515.35 Mn | 147.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.23 Mn |
| Mar 31, 2026 | 11.61 Mn |
| Dec 31, 2025 | 11.99 Mn |
| Sep 30, 2025 | 12.35 Mn |
| Jun 30, 2025 | 12.72 Mn |
| Mar 31, 2025 | 13.07 Mn |
| Dec 31, 2024 | 13.42 Mn |
| Sep 30, 2024 | 13.76 Mn |
| Jun 30, 2024 | 14.10 Mn |
| Mar 31, 2024 | 14.43 Mn |
| Dec 31, 2023 | 14.76 Mn |
| Sep 30, 2023 | 15.07 Mn |
| Jun 30, 2023 | 15.39 Mn |
| Mar 31, 2023 | 15.70 Mn |
| Dec 31, 2022 | 16.00 Mn |
| Mar 31, 2022 | 15.87 Mn |
API Access
Ovid Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();